T. Rowe Price Associates’s LifeMD LFMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Buy |
17,753
+1,470
| +9% | +$20K | ﹤0.01% | 2622 |
|
|
2025
Q1 | $89K | Buy |
16,283
+2,271
| +16% | +$12.4K | ﹤0.01% | 2843 |
|
|
2024
Q4 | $70K | Buy |
14,012
+2,895
| +26% | +$14.5K | ﹤0.01% | 2879 |
|
|
2024
Q3 | $59K | Hold |
11,117
| – | – | ﹤0.01% | 2907 |
|
|
2024
Q2 | $0 | Buy |
+11,117
| New | – | ﹤0.01% | 2980 |
|
|
2022
Q3 | – | Sell |
-18,900
| Closed | -$39K | – | 3005 |
|
|
2022
Q2 | $39K | Hold |
18,900
| – | – | ﹤0.01% | 2879 |
|
|
2022
Q1 | $67K | Hold |
18,900
| – | – | ﹤0.01% | 2890 |
|
|
2021
Q4 | $73K | Hold |
18,900
| – | – | ﹤0.01% | 2902 |
|
|
2021
Q3 | $117K | Sell |
18,900
-6,100
| -24% | -$37.8K | ﹤0.01% | 2813 |
|
|
2021
Q2 | $295K | Buy |
+25,000
| New | +$295K | ﹤0.01% | 2597 |
|